Increased circulating placental growth factor during percutaneous coronary intervention is associated with applied radiocontrast agent

Coronary Artery Disease

Volumn 20, Issue 2, 2009, Pages 130-137

  Steppich, Birgit Annette ^a   Kaufmann, Jan ^a   Sepp, Dominik ^a   Kunert, Katharina ^a   Rutz, Tobias ^a   Stratz, Christian ^a   Ott, Ilka ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute coronary syndromes; Placental growth factor; Radiocontrast media; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; MESSENGER RNA; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; ANTICOAGULANT AGENT; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; DRUG DERIVATIVE; IL6 PROTEIN, HUMAN; IODIXANOL; IODOBENZOIC ACID DERIVATIVE; IOMEPROL; IOPAMIDOL; PLACENTA PROTEIN; PRODUCT PLACENTA GROWTH FACTOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVASCULARIZATION; STABLE ANGINA PECTORIS; UMBILICAL VEIN; ANGINA PECTORIS; BLOOD; CASE CONTROL STUDY; CELL CULTURE; CORONARY ARTERY OBSTRUCTION; DOSE RESPONSE; DRUG EFFECT; HOSPITALIZATION; METABOLISM; RADIOGRAPHY; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UPREGULATION;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELLS, CULTURED; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HEPARIN; HUMANS; INTERLEUKIN-6; IOPAMIDOL; MYOCARDIAL INFARCTION; PREGNANCY PROTEINS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; TRIIODOBENZOIC ACIDS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 66349111468     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283229d97     Document Type: Article

References (37)

1. Heeschen C, Dimmeler S, Fichtlscherer S, Hamm CW, Berger J, Simoons ML, et al. Prognostic value of placental growth factor in patients with acute chest pain. JAMA 2004; 291:435-441.
2. Lenderink T, Heeschen C, Fichtlscherer S, Dimmeler S, Hamm CW, Zeiher AM, et al. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol 2006; 47:307-311.
3. Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cell Mol Dis 2007; 38:258-268.
4. Luttun A, Tjwa M, Carmeliet P. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders. Ann N Y Acad Sci 2002; 979:80-93.
5. Autiero M, Luttun A, Tjwa M, Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 2003; 1:1356-1370.
6. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002; 8:831-840.
7. Selvaraj SK, Giri RK, Perelman N, Johnson C, Malik P, Kalra VK. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 2003; 102:1515-1524.
8. Pilarczyk K, Sattler KJ, Galili O, Versari D, Olson ML, Meyer FB, et al. Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization. Atherosclerosis 2008; 196:333-340.
9. Blake GJ, Ridker PM. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 2003; 41:37S-42S.
10. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331:417-424.
11. Heeschen C, Hamm CW, Bruemmer J, Simoons ML. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. J Am Coll Cardiol 2000; 35:1535-1542.
12. Serrano CV Jr, Ramires JA, Venturinelli M, Arie S, D'Amico E, Zweier JL, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 1997; 29:1276-1283.
13. Azar RR, McKay RG, Kiernan FJ, Seecharran B, Feng YJ, Fram DB, et al. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 1997; 80:1476-1478.
14. Saleh N, Svane B, Jensen J, Hansson LO, Nordin M, Tornvall P. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris. Am Heart J 2005; 149:876-882.
15. Nakamura T, Funayama H, Kubo N, Yasu T, Kawakami M, Momomura SI, et al. Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy. Int J Cardiol 2008 [Epub ahead of print]
16. Iwama H, Uemura S, Naya N, Imagawa K,Takemoto Y, Asai O, et al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol 2006; 47:1559-1567.
17. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006; 203:1447-1458.
18. Ott I, Neumann FJ, Kenngott S, Gawaz M, Schomig A. Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cardiol 1998; 82:938-942.
19. Schick CS, Haller C. Comparative cytotoxicity of ionic and non-ionic radiocontrast agents on MDCK cell monolayers in vitro. Nephrol Dial Transplant 1999; 14:342-347.
20. Tarnow L, Astrup AS, Parving HH. Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Scand J Clin Lab Invest Suppl 2005; 240:73-79.
21. Green CJ, Lichtlen P, Huynh NT, Yanovsky M, Laderoute KR, Schaffner W, et al. Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res2001; 61:2696-2703.
22. Fauser C, Ullisch EV, Kubler W, Haller C. Differential effects of radiocontrast agents on human umbilical vein endothelial cells: cytotoxicity and modulators of thrombogenicity. Eur J Med Res 2001; 6:465-472.
23. Heinrich MC, Kuhlmann MK, Kohlbacher S, Scheer M, Grgic A, Heckmann MB, et al. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study. Radiology 2007; 242:425-434.
24. Sung JM, Shu GH, Tsai JC, Huang JJ. Radiocontrast media induced endothelin-1 mRNA expression and peptide release in porcine aortic endothelial cells. J Formos Med Assoc 1995; 94:77-86.
25. Andreucci M, Fuiano G, Presta P, Esposito P, Faga T, Bisesti V, et al. Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells. Biochem Pharmacol 2006; 72:1334-1342.
26. Albanese JR, Venditto JA, Patel GC, Ambrose JA. Effects of ionic and nonionic contrast media on in vitro and in vivo platelet activation. Am J Cardiol 1995; 76:1059-1063.
27. Qureshi NR, den Heijer P, Crijns HJ. Percutaneous coronary angioscopic comparison of thrombus formation during percutaneous coronary angioplasty with ionic and nonionic low osmolality contrast media in unstable angina. Am J Cardiol 1997; 80:700-704.
28. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992; 6:2591-2599.
29. Parvez Z, Khan T, Moncada R. Ultrastructural changes in rat aortic endothelium during contrast media infusion. Invest Radiol 1985; 20:407-412.
30. Laerum F. Acute damage to human endothelial cells by brief exposure to contrast media in vitro. Radiology 1983; 147:681-684.
31. Mohammed KA, Nasreen N, Tepper RS, Antony VB. Cyclic stretch induces PlGF expression in bronchial airway epithelial cells via nitric oxide release. Am J Physiol Lung Cell Mol Physiol 2007; 292:L559-L566.
32. Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen - a review. Placenta 2000; 21 (Suppl A):S16-S24.
33. Bottomley MJ, Webb NJ, Watson CJ, Holt L, Bukhari M, Denton J, et al. Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin Exp Immunol 2000; 119:182-188.
34. Xu L, Cochran DM, Tong RT, Winkler F, Kashiwagi S, Jain RK, et al. Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models. Cancer Res 2006; 66:3971-3977.
35. Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. J Biol Chem 1996; 271:3154-3162.
36. Eriksson A, Cao R, Pawliuk R, Berg SM, Tsang M, Zhou D, et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell 2002; 1:99-108.
37. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, et al. Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003; 9:936-943.